In the US, Drixoral (dexbrompheniramine/pseudoephedrine systemic) is a member of the drug class upper respiratory combinations and is used to treat Allergic Rhinitis, Cold Symptoms, Nasal Congestion and Sinus Symptoms.
- Drixoral Cold and Allergy
- Drixoral Cold/Flu controlled-release tablets
- Drixoral Decongestant Non-Drowsy
- Drixoral Non-Drowsy Sustained-Release Capsules
- Drixoral Sinus sustained-release tablets
Ingredient matches for Drixoral
Dexbrompheniramine maleate (a derivative of Dexbrompheniramine) is reported as an ingredient of Drixoral in the following countries:
Pseudoephedrine sulfate (a derivative of Pseudoephedrine) is reported as an ingredient of Drixoral in the following countries:
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.